BUprenorphine Versus Morphine for Postcesarean Analgesia (BUMP) (NCT07786012)

🧪 Interventions in This Study

• buprenorphine (DRUG)
• morphine (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Mount Sinai Hospital — New York, New York

📞 Contact the Study Coordinator

Phone: (212) 241-7475

Email: daniel.katz@mountsinai.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Cesarean Delivery

• IC-CS Risk: Patient Outcomes — Ann Arbor, Michigan
• Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery — New York, New York
• Duration of Urinary Catheterization Following Cesarean Deliveries Under Neuraxial Anesthesia — Vancouver, British Columbia
• Suzetrigine for Opioid-Free Recovery After Cesarean Delivery — Austin, Texas
• Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies — Philadelphia, Pennsylvania

Explore by condition: All Cesarean Delivery clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.